Quantcast
Last updated on April 17, 2014 at 13:47 EDT

Latest Paracetamol Stories

2013-05-24 23:22:04

The firm is actively filing Tylenol lawsuits on behalf of those who allegedly suffered liver damage and other serious complications related to their use of Tylenol. (PRWEB) May 23, 2013 The Rottenstein Law Group LLP, a New York-based nationwide mass torts law firm, has created the Tylenol Lawsuit Information Center at http://www.rotlaw.com/tylenol, dedicated to issues that apply to Tylenol users and those who are considering filing lawsuits. The painkiller Tylenol (acetaminophen) has been...

2013-05-21 16:27:01

SCHOFIELD, Wis., May 21, 2013 /PRNewswire/ -- PuraMed BioScience®, Inc., (OTCBB:PMBS), a researcher, developer, and marketer of over-the-counter (OTC) medicinal and healthcare products, announced the results of clinical trials that found its over-the-counter migraine medication product, LipiGesic(®) M, has "robust efficacy". With recent statistics showing nearly 39 million Americans suffering from migraine headaches, studies show that LipiGesic M provides a safe, highly effective OTC...

2013-05-16 23:20:38

The law offices of d´Oliveira & Associates have released a new infographic on possible Tylenol side effects which include liver damage. (PRWEB) May 16, 2013 Tylenol (acetminophen) is an over-the-counter drug used to reduce pain, fever, and a variety of other symptoms related to allergies and illness. Tylenol was originally approved in 1951 and was first marketed in 1953 (i). It is manufactured by McNeil Consumer Healthcare, which is now a subsidiary of Johnson & Johnson. The...

2013-05-14 23:33:35

Aspirin, ibuprofen, and acetaminophen are the most commonly used drugs for pain control. Dr. J G Moellendorf, DC, ND, LCP discusses recent research from the audiology profession about increased hearing loss with analgesic use. Sturgeon Bay, WI (PRWEB) May 14, 2013 Sturgeon Bay, Wisconsin Chiropractor and Naturopath, Dr. J G Moellendorf, DC, ND, LCP notes that while aspirin has been known for decades to cause ringing in the ears, stomach ulcers,and kidney problems, doctors are concerned that...

2013-05-13 08:28:25

-Full Data from COSIRA Trial Expected Around Year's End--Initial Data from Reducer Patient Registries To Be Presented at EuroPCR 2013- TSX Venture Exchange: NVC VANCOUVER, May 13, 2013 /CNW/ - Neovasc Inc. (TSXV: NVC), today announced the completion of patient enrollment in its COSIRA trial designed to further assess the efficacy and safety of the Neovasc Reducer(TM), a novel percutaneous device for the treatment of refractory angina.  The COSIRA (Coronary Sinus Reducer for...

2013-05-09 23:51:00

Pennsylvania judge will coordinate numerous lawsuits alleging liver damage from Tylenol products in newly created multidistrict litigation. Consolidation of cases will not affect ability of consumers to seek free consultations from Resource4thePeople attorneys investigating such cases. San Diego, CA (PRWEB) May 08, 2013 http://www.resource4thepeople.com/defectivedrugs/acetaminophen.html Resource4thePeople today updates the status of numerous lawsuits alleging links between Tylenol products...

2013-05-02 23:24:33

http://www.DrugRisks.com is the most useful source on the web for prescription medication alerts, side effects and legal news. Visit us today Chicago, IL (PRWEB) May 02, 2013 The medication resource center DrugRisks.com is announcing new information on the site for patients taking the blood thinner Pradaxa. A federal judge has ordered drug maker Boehringer Ingelheim to disclose employee reviews and bonuses related to the blood thinner Pradaxa****. DrugRisks was created to improve the safety...

2013-05-02 12:28:37

2013 Q1 NME FDA approvals indicates drug names are trending to longer lengths, more syllables and greater distinction. NEW YORK, May 2, 2013 /PRNewswire-iReach/ -- For the first quarter of the 2013 calendar year, the FDA's Center for Drug Evaluation and Research (CDER) has approved nine new molecular entities. A total of 39 novel new medicines were approved in 2012, the highest total in sixteen years. Our conclusions are based on a comparison of the average number of letters and...

2013-05-01 08:37:31

Company also named Chris Toepker as EVP Product Development SCOTTSDALE, Ariz., May 1, 2013 /PRNewswire/ -- Kuboo, Inc., dba Safe Communications, Pink Sheets (SGTB). announced today that Shouvik Bhattacharyya, an International Entrepreneurial Executive that has built and managed several global services and technology firms, has been named the company's new President. Bhattacharyya has served as CEO of public and private companies in the US, Europe and India. He is also a partner in...

2013-05-01 08:31:07

PDUFA goal date set for October 17, 2013 ATLANTA, May 1, 2013 /PRNewswire/ -- Alimera Sciences, Inc. (NASDAQ: ALIM) (Alimera), a biopharmaceutical company that specializes in the research, development and commercialization of prescription ophthalmic pharmaceuticals, today announced that its recent resubmission of the New Drug Application (NDA) for ILUVIEN(®) has been acknowledged as received by the U.S. Food and Drug Administration (FDA) as a complete class 2 response to the...